HarvalaHStewartCMullerK. High risk of cytomegalovirus infection following solid organ transplantation despite prophylactic therapy. J Med Virol. 2013;85(5):893–898. doi:10.1002/jmv.23539.
2.
LuanFL. Six-month low-dose valganciclovir prophylaxis in cytomegalovirus D+/R- kidney transplant patients receiving thymoglobulin induction. Transplant Proc. 2013;45(1):175–177. doi:10.1016/j.transproceed.2012.04.036.
3.
SmithSRButterlyDWConlonPJHarlandRCEmovonOE. Incidence of cytomegalovirus disease in renal transplantation without antilymphocyte induction: is prophylaxis necessary?Transplant Proc. 1998;30(5):2097–2099.
